speb/financial-data huggingface dataset:
ABRA.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 8209169.00
ABRA.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 24378362.00
ABRA.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 7420066.00
ABRA.TO income_statement (annual, 2023-12-31) — Total Unusual Items: 11338538.00
ABRA.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 11338538.00
ABRA.TO balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 7420066.00
ABRA.TO balance_sheet (annual, 2023-12-31) — Working Capital: 4501658.00
ABRA.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 125396714.00
ABRA.TO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.04
ABRA.TO income_statement (quarterly, 2024-09-30) — Cost Of Revenue: 0.00
ABRA.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 125396714.00
ABRA.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.04
ABRA.TO income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: 0.00
ABRA.TO income_statement (quarterly, 2024-09-30) — Gross Profit: 0.00
ABRA.TO cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
ABRA.TO cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
ABRA.TO cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
ABRA.TO cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: 0.00
ABRA.TO balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 6156879.00
ABRA.TO income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 14718.00
ABRA.TO balance_sheet (quarterly, 2024-09-30) — Other Payable: 8410965.00
ABRA.TO income_statement (quarterly, 2024-09-30) — Reconciled Cost Of Revenue: 0.00
ABRA.TO cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
ABRA.TO cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: 0.00
ABRA.TO income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
ABRA.TO balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 0.00
ABRA.TO income_statement (annual, 2024-12-31) — +Operating Expense: 26437169.00
ABRA.TO income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 1641818.00
ABRA.TO balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 1641818.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 281949.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -26607.00
ABRA.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 121914700.00
ABRA.TO income_statement (annual, 2024-12-31) — Basic EPS: -0.21
ABRA.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 2797365.00
ABRA.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -3123199.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 123609217.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 13726498.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 13726498.00
ABRA.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 27762169.00
ABRA.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 6770397.00
ABRA.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -23105250.00
ABRA.TO cash_flow (annual, 2024-12-31) — Cash From Discontinued Financing Activities: 0.00
ABRA.TO cash_flow (annual, 2024-12-31) — Cash From Discontinued Investing Activities: 0.00
ABRA.TO cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: -22341.00
ABRA.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 851775.00
ABRA.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -22989.00
ABRA.TO cash_flow (annual, 2024-12-31) — Change In Receivables: 165134.00
ABRA.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 993920.00
ABRA.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 11404975.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Common Stock: 123609217.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 28751518.00
ABRA.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 19958813.00
ABRA.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 1561919.00
ABRA.TO income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 443158.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Current Assets: 14081615.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 10928787.00
ABRA.TO cash_flow (annual, 2024-12-31) — Depreciation: 20894.00
ABRA.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 20894.00
ABRA.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 20894.00
ABRA.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 121914700.00
ABRA.TO income_statement (annual, 2024-12-31) — Diluted EPS: -0.21
ABRA.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -25096305.00
ABRA.TO income_statement (annual, 2024-12-31) — EBIT: -23920146.00
ABRA.TO income_statement (annual, 2024-12-31) — EBITDA: -23899252.00
ABRA.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -475842.00
ABRA.TO cash_flow (annual, 2024-12-31) — End Cash Position: 13726498.00
ABRA.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 27762169.00
ABRA.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: -26250790.00
ABRA.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -3901435.00
ABRA.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -804785.00
ABRA.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 0.00
ABRA.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 2950388.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 9657335.00
ABRA.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 6089435.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 25625297.00
ABRA.TO income_statement (annual, 2024-12-31) — Gross Profit: -1561919.00
ABRA.TO income_statement (quarterly, 2024-12-31) — Gross Profit: -443158.00
ABRA.TO income_statement (annual, 2024-12-31) — Insurance And Claims: 167610.00
ABRA.TO income_statement (annual, 2024-12-31) — Interest Expense: 1156744.00
ABRA.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1156744.00
ABRA.TO income_statement (annual, 2024-12-31) — Interest Income: 557091.00
ABRA.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 557091.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 28751518.00
ABRA.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 6770397.00
ABRA.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 19958813.00
ABRA.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
ABRA.TO cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
ABRA.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 19958813.00
ABRA.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 950752.00
ABRA.TO income_statement (annual, 2024-12-31) — Net Income: -25096305.00
ABRA.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -25096305.00
ABRA.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -25076890.00
ABRA.TO income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: -19415.00
ABRA.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -25096305.00
ABRA.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -25076890.00
ABRA.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -25076890.00
ABRA.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -25096305.00
ABRA.TO income_statement (annual, 2024-12-31) — Net Interest Income: -599653.00
ABRA.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 9893596.00
ABRA.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
ABRA.TO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
ABRA.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
ABRA.TO cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
ABRA.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -599653.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Net PPE: 25598690.00
ABRA.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -3123199.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 28751518.00
ABRA.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: -26849640.00
ABRA.TO income_statement (annual, 2024-12-31) — Normalized Income: -28027278.00
ABRA.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -23127591.00
ABRA.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -2950683.00
ABRA.TO income_statement (annual, 2024-12-31) — Operating Income: -27999088.00
ABRA.TO income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 128693370.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 9657335.00
ABRA.TO income_statement (annual, 2024-12-31) — Other Gand A: 1988403.00
ABRA.TO income_statement (annual, 2024-12-31) — Other Income Expense: 3521851.00
ABRA.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1156744.00
ABRA.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 571463.00
ABRA.TO income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -14629.00
ABRA.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 20347734.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Other Payable: 9286969.00
ABRA.TO balance_sheet (quarterly, 2024-12-31) — Other Payable: 9286969.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Other Properties: 25625297.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
ABRA.TO balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Payables: 10928787.00
ABRA.TO balance_sheet (quarterly, 2024-12-31) — Payables: 10928787.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 10928787.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 73168.00
ABRA.TO income_statement (annual, 2024-12-31) — Pretax Income: -25076890.00
ABRA.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 7803356.00
ABRA.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -18659951.00
ABRA.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -3123199.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Receivables: 281949.00
ABRA.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1561919.00
ABRA.TO income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 443158.00
ABRA.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 20894.00
ABRA.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
ABRA.TO cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -104515034.00
ABRA.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 3933422.00
ABRA.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 28553547.00
ABRA.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 6089435.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Share Issued: 128693370.00
ABRA.TO income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
ABRA.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 2750765.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 28751518.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 28751518.00
ABRA.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ABRA.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Total Assets: 39680305.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 28751518.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 28751518.00
ABRA.TO income_statement (annual, 2024-12-31) — Total Expenses: 27999088.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 10928787.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 25598690.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ABRA.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 2950388.00
ABRA.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 2950388.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
ABRA.TO balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
ABRA.TO balance_sheet (annual, 2024-12-31) — Working Capital: 3152828.00
ABRA.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 9596000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2246422.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 294294.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -39803.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 142269000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.06
ABRA.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 13726000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1669000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 180304742.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 61489402.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 61489402.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 56389000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1049000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -7543000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Financing Activities: 0.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Investing Activities: 0.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: -16000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 406000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 11000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -4000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 413000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 47781000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 180304742.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 77224786.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 56220000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 61846226.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 11850332.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 18000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 18000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 18000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 142269000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.06
ABRA.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -9023000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — EBIT: -8692000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — EBITDA: -8674000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -18000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 61489000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 56389000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -9228000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -620000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 644000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 10628344.00
ABRA.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2979000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 27268695.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Insurance And Claims: 51000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 325000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 325000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Interest Income: 253000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 253000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 77224786.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1049000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 56220000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 56220000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -23000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Net Income: -9023000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -9023000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -9017000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -6000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -9023000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -9017000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -9017000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -9023000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -72000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 620000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -72000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 27228892.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1669000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 77224786.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -9318000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -9661000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -7559000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -643000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Operating Income: -9596000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 152548356.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 10628344.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 1300000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 651000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 325000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 7000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 6617000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Other Payable: 9603910.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 27268695.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Payables: 11850332.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 11850332.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 62530.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -9017000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 169000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -5165000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1669000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 294294.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 18000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -113708300.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 1628000.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 5785000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2979000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 152548356.00
ABRA.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1361000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 77224786.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 77224786.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 89075118.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 77224786.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 77224786.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 9596000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 11850332.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 27228892.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 644000.00
ABRA.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 644000.00
ABRA.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 49995894.00
ABRA.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 12459161.00
ABRA.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4025540.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 180133.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -56103.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 152558631.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.08
ABRA.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 61489000.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -55276.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 180475232.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 27846548.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 41769423.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -9559296.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -14108774.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -9964174.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -587454.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 2173265.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 105816.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1691627.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -33616244.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 180475232.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 64055433.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: -428.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 42204178.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 4025540.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 18460.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 18460.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 18460.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 152558631.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.08
ABRA.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -12880530.00
ABRA.TO income_statement (quarterly, 2025-06-30) — EBIT: -12837394.00
ABRA.TO income_statement (quarterly, 2025-06-30) — EBITDA: -12818934.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -26706.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 27846548.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -9559296.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -10003450.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -166502.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: -88205.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -1506712.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 10169031.00
ABRA.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 3114773.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 25932898.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Insurance And Claims: 37827.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 36376.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 36376.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Interest Income: 734745.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 734745.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 64055433.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -14108774.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: -428.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -428.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 303092.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Net Income: -12880530.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -12880530.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -12873770.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: -6760.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -12880530.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -12873770.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -12886409.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -12880530.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 698369.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -14053498.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -9660618.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 698369.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 25876795.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -55276.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 64055433.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -11224017.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -11278853.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -9948174.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 136590.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Operating Income: -12459161.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 152603356.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 10169031.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 1748802.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -1112978.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 97236.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 481939.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 9344388.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 25932898.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 13922875.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Payables: 4025540.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 4025540.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 254622.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -12873770.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 101750.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -22800348.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -55276.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 180133.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 18460.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -9660618.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -126588830.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 1328144.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 8746850.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3114773.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 152603356.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -88205.00
ABRA.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 978322.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 64055433.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 64055433.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 68080973.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 64055433.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 64055433.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 12459161.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4025540.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 25876795.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -1594917.00
ABRA.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -1594917.00
ABRA.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 38178638.00
ABRA.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 17489606.00
ABRA.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4133919.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 254477.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -77313.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 152689269.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.11
ABRA.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 27846548.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1161447.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 180955775.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 12880714.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 28277803.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 275175.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -960604.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -13233319.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2476033.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -2289240.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -70660.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 116133.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -13936737.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 180955775.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 51015059.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 0.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 28710423.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4133919.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 19888.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 19888.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 19888.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 152689269.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.11
ABRA.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -16569497.00
ABRA.TO income_statement (quarterly, 2025-09-30) — EBIT: -16569497.00
ABRA.TO income_statement (quarterly, 2025-09-30) — EBITDA: -16549609.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -1029097.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 12880714.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 275175.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -14412755.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 121873.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 0.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 574718.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 13217611.00
ABRA.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4234973.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 26515868.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 0.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Insurance And Claims: 39435.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 0.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 0.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Interest Income: 345391.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 345391.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 51015059.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -960604.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 673071.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Net Income: -16569497.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -16569497.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -16569497.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -16569497.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -16569497.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -16557127.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -16569497.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 345391.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 200843.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 345391.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 26438555.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1161447.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 0.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 51015059.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -17124327.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -17144215.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -13251308.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 794944.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Operating Income: -17489606.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 152749856.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 13217611.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 1263553.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 574718.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -179846.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 13254633.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 26515868.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 15397089.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Payables: 4133919.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4133919.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 178143.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -16569497.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 275175.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -10435079.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1161447.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 254477.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 0.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 19888.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -143158327.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 2931985.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 10635922.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4234973.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 152749856.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: 0.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
ABRA.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2572689.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 51015059.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 51015059.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 55148978.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 51015059.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 51015059.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 17489606.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4133919.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 26438555.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 574718.00
ABRA.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 574718.00
ABRA.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 24576504.00
ABRA.TO income_statement (annual, 2025-12-31) — +Operating Expense: 56402069.00
ABRA.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 16857935.00
ABRA.TO income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
ABRA.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
ABRA.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 7244333.00
ABRA.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 7244333.00
ABRA.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 394907.00
ABRA.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 394907.00
ABRA.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -95875.00
ABRA.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -95875.00
ABRA.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 151403721.00
ABRA.TO income_statement (annual, 2025-12-31) — Basic EPS: -0.38
ABRA.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 13726498.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 12880714.00
ABRA.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -6581579.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -3695856.00
ABRA.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 226693884.00
ABRA.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 226693884.00
ABRA.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 29411799.00
ABRA.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 29411799.00
ABRA.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 58458662.00
ABRA.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 58458662.00
ABRA.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 91977844.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 44872965.00
ABRA.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -31402611.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -15284233.00
ABRA.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -44153281.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -13412788.00
ABRA.TO cash_flow (annual, 2025-12-31) — Cash From Discontinued Financing Activities: 0.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Financing Activities: 0.00
ABRA.TO cash_flow (annual, 2025-12-31) — Cash From Discontinued Investing Activities: 0.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Investing Activities: 0.00
ABRA.TO cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: -17989.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Operating Activities: 0.00
ABRA.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 5604450.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 3309871.00
ABRA.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -233289.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -128314.00
ABRA.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -109274.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -140430.00
ABRA.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 5261887.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 3041127.00
ABRA.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 16403963.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 16175944.00
ABRA.TO balance_sheet (annual, 2025-12-31) — Common Stock: 226693884.00
ABRA.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 226693884.00
ABRA.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 78817058.00
ABRA.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 78817058.00
ABRA.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 101459259.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 45239687.00
ABRA.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 2210071.00
ABRA.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2892221.00
ABRA.TO balance_sheet (annual, 2025-12-31) — Current Assets: 59160026.00
ABRA.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 59160026.00
ABRA.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 7244333.00
ABRA.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 7244333.00
ABRA.TO cash_flow (annual, 2025-12-31) — Depreciation: 76456.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 20108.00
ABRA.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 76456.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 20108.00
ABRA.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 76456.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 20108.00
ABRA.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 151403721.00
ABRA.TO income_statement (annual, 2025-12-31) — Diluted EPS: -0.38
ABRA.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -57638217.00
ABRA.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -19165311.00
ABRA.TO income_statement (annual, 2025-12-31) — EBIT: -57264684.00
ABRA.TO income_statement (quarterly, 2025-12-31) — EBIT: -19165311.00
ABRA.TO income_statement (annual, 2025-12-31) — EBITDA: -57188228.00
ABRA.TO income_statement (quarterly, 2025-12-31) — EBITDA: -19145203.00
ABRA.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -718662.00
ABRA.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 355141.00